SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.
SignalRx Pharmaceuticals has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in April 2023.
SignalRx Pharmaceuticals is headquartered in Omaha, United States.
SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.
SignalRx Pharmaceuticals is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SignalRx Pharmaceuticals — Funding & Investors." VCBacked, April 26, 2023, https://www.vcbacked.co/company/signalrx-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2023). SignalRx Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/signalrx-pharmaceuticals
{{cite web |title=SignalRx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/signalrx-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated